| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/06/2000 | WO1999041282A8 Therapeutic uses of keratinocyte growth factor-2 |
| 07/06/2000 | WO1999040119A9 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 07/06/2000 | WO1998046776A9 Plant fatty acid synthases and use in improved methods for production of medium-chain fatty acids |
| 07/06/2000 | DE19900681A1 Production of an endotoxin-free nucleic acid solution comprises binding nucleic acids on a microporous weakly basic anion-exchange membrane and eluting them with buffer of high ionic strength |
| 07/06/2000 | DE19860801A1 Rekombinanter Wachstumsfaktor mit der biologischen Aktivität eines G-CSF (Granulocyte Colony Stimulating Factor) Recombinant growth factor having the biological activity of a G-CSF (Granulocyte Colony Stimulating Factor) |
| 07/06/2000 | DE19860642A1 Antisense-Oligonukleotid zur Hemmung der Expression des Adhäsionsmoleküls very late antigen 4 (VLA-4) in menschlichen Zellen An antisense oligonucleotide for inhibiting the expression of the adhesion molecule very late antigen-4 (VLA-4) in human cells |
| 07/06/2000 | DE19860602A1 Gentransfervektor für die Diagnostik und die Therapie von malignen Tumoren Gene transfer vector for the diagnosis and therapy of malignant tumors |
| 07/06/2000 | CA2729739A1 Composite arrays utilizing microspheres |
| 07/06/2000 | CA2719413A1 Compositions and methods for packaging of alphavirus vectors |
| 07/06/2000 | CA2358687A1 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | CA2358385A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | CA2358094A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | CA2357601A1 Mutation scanning array, and methods of use thereof |
| 07/06/2000 | CA2357036A1 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein |
| 07/06/2000 | CA2356894A1 Removal of biological contaminants |
| 07/06/2000 | CA2356891A1 Methods for robust discrimination of profiles |
| 07/06/2000 | CA2356877A1 Gene therapy for pulmonary edema using adenovirus vectors encoding na,k-atpase |
| 07/06/2000 | CA2356873A1 Method for determining therapeutic index from gene expression profiles |
| 07/06/2000 | CA2356834A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 07/06/2000 | CA2356755A1 Superantigens |
| 07/06/2000 | CA2356740A1 Gram-positive bacteria deprived of htra proteasic activity and their uses |
| 07/06/2000 | CA2356669A1 Methods for using mycobacterium tuberculosis molecules as immunological adjuvants |
| 07/06/2000 | CA2356661A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | CA2356648A1 Methods of characterizing drug activities using consensus profiles |
| 07/06/2000 | CA2356621A1 Assay for identifying compounds which affect stability of mrna |
| 07/06/2000 | CA2356608A1 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides abd uses thereof |
| 07/06/2000 | CA2356551A1 Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 07/06/2000 | CA2356548A1 Human brainiac-5 |
| 07/06/2000 | CA2356542A1 Peptidoglycan recognition proteins |
| 07/06/2000 | CA2356446A1 Pyruvate carboxylase from corynebacterium glutamicum |
| 07/06/2000 | CA2356424A1 Serine protease inhibitor |
| 07/06/2000 | CA2356354A1 Apparatus and methods for efficient processing of biological samples on slides |
| 07/06/2000 | CA2356243A1 Novel guanosine triphosphate (gtp) binding protein-coupled receptor proteins |
| 07/06/2000 | CA2356125A1 Control of gene expression in eukaryotes |
| 07/06/2000 | CA2356057A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2355883A1 Neutralizing assay using human papillomavirus virus-like particles |
| 07/06/2000 | CA2355875A1 Tissue collection devices containing biosensors |
| 07/06/2000 | CA2355658A1 Genotyping cytochrome expression |
| 07/06/2000 | CA2355468A1 Glycosyl phosphatidy linositol specific phospholipase d proteins and uses thereof |
| 07/06/2000 | CA2355254A1 Use of peptide |
| 07/06/2000 | CA2355227A1 Targeted gene transfer using g protein coupled receptors |
| 07/06/2000 | CA2355131A1 Detergent compositions comprising phenol oxidizing enzymes from fungi |
| 07/06/2000 | CA2354562A1 Transfectacons comprising calcium phosphate and a nucleic acid |
| 07/06/2000 | CA2354542A1 Transgenic rodents and rodent cell lines expressing hiv co-receptors |
| 07/06/2000 | CA2354431A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2354027A1 Il-1 related polypeptides |
| 07/06/2000 | CA2334958A1 Peptide mimics useful for treating disease |
| 07/06/2000 | CA2321672A1 Caspase-8 interacting proteins |
| 07/06/2000 | CA2292798A1 Novel vector for introducing a gene into a plant using a selectable marker |
| 07/05/2000 | EP1016864A2 Process for microfabrication of integrated PCR-CE device and product produced by the same |
| 07/05/2000 | EP1016729A1 METHOD FOR SYNTHESIZING cDNA FROM mRNA SAMPLE |
| 07/05/2000 | EP1016727A1 Gene therapy to promote angiogenesis. |
| 07/05/2000 | EP1016726A1 Gene therapy to promote angiogenesis |
| 07/05/2000 | EP1016725A1 Plasmids originating in ammonia oxidizing bacteria and use of the same |
| 07/05/2000 | EP1016724A2 Plasmids expressing the trigger factors GroEL or GroES |
| 07/05/2000 | EP1016723A1 Recombinant synthesis of beta-Lipotropin and other peptides |
| 07/05/2000 | EP1016722A1 Method of dwarfing plants |
| 07/05/2000 | EP1016721A1 NOVEL Fas LIGAND DERIVATIVE |
| 07/05/2000 | EP1016720A1 Mammalian genes participating in circadian period |
| 07/05/2000 | EP1016719A1 Dna participating in regulation of expression of a pebp2 alpha a gene, and use thereof |
| 07/05/2000 | EP1016718A1 PROTEIN HAVING Zn FINGER-LIKE MOTIF |
| 07/05/2000 | EP1016717A1 Novel protein remarkably expressed in hepatic cancer, gene encoding the same, antibody thereto, and method for detecting the expression thereof |
| 07/05/2000 | EP1016716A2 Dna encoding a growth factor specific for epithelial cells |
| 07/05/2000 | EP1016715A1 Oligonucleotides having a conserved G4 core sequence |
| 07/05/2000 | EP1016710A2 Method for producing L-amino acids |
| 07/05/2000 | EP1016419A2 Non-invasive localization of a light-emitting conjugate in a mammal |
| 07/05/2000 | EP1016418A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/05/2000 | EP1015890A1 Recombinant rabbit tissue factor based prothrombin time reagent |
| 07/05/2000 | EP1015886A1 Detection of measles virus-specific antibodies |
| 07/05/2000 | EP1015643A2 Method and reagents for analyzing the nucleotide sequence of nucleic acids |
| 07/05/2000 | EP1015642A1 Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 07/05/2000 | EP1015640A2 Method for synthesising and amplifying nucleic acids |
| 07/05/2000 | EP1015639A1 Methods of evaluating transplant rejection |
| 07/05/2000 | EP1015638A1 De novo polynucleotide synthesis using rolling templates |
| 07/05/2000 | EP1015636A1 Dna bracketing locus compatible standards for electrophoresis |
| 07/05/2000 | EP1015632A1 Characterising nucleic acid by mass spectrometry |
| 07/05/2000 | EP1015631A1 Genetic polymorphisms in the microsomal triglyceride transfer protein promoter and uses thereof |
| 07/05/2000 | EP1015630A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/05/2000 | EP1015629A1 Bioconjugation of oligonucleotides |
| 07/05/2000 | EP1015628A1 Large scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6 |
| 07/05/2000 | EP1015627A1 Method for detecting a target compound using a nucleic acid ligand |
| 07/05/2000 | EP1015626A1 Method of monitoring the competitiveness of a microbial strain |
| 07/05/2000 | EP1015624A2 P53-induced apoptosis |
| 07/05/2000 | EP1015622A1 Practical in vitro sialylation of recombinant glycoproteins |
| 07/05/2000 | EP1015621A2 Method for microbial production of amino acids of the aspartate and/or glutamate family and agents which can be used in said method |
| 07/05/2000 | EP1015620A1 Plasmids for construction of eukaryotic viral vectors |
| 07/05/2000 | EP1015619A1 Methods and cell line useful for production of recombinant adeno-associated viruses |
| 07/05/2000 | EP1015618A1 Preparing membrane receptors from extracellular baciloviruses |
| 07/05/2000 | EP1015617A1 Sv40 viral vectors for targeted integration into cells |
| 07/05/2000 | EP1015616A2 Intrabody-mediated control of immune reactions |
| 07/05/2000 | EP1015615A1 Targeted gene transfer using g protein coupled receptors |
| 07/05/2000 | EP1015614A1 Isoflavone biosynthetic enzymes |
| 07/05/2000 | EP1015613A1 Control pod dehiscence or shatter |
| 07/05/2000 | EP1015612A1 Process for preparing recombinant proteins using highly efficient expression vector from saccharomyces cerevisiae |
| 07/05/2000 | EP1015611A1 Methods for producing polypeptides in respiratory-deficient cells |
| 07/05/2000 | EP1015610A2 Medicament for treating a manifested lyme disease |
| 07/05/2000 | EP1015609A1 A novel generation of cloned horseshoe crab recombinant factor c for detection and removal of endotoxin |
| 07/05/2000 | EP1015608A1 Methods of assaying receptor activity and constructs useful in such methods |
| 07/05/2000 | EP1015607A1 Dna encoding a ras carboxyl-terminal processing protein |
| 07/05/2000 | EP1015606A2 Proteases from gram-positive organisms |